Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y.
Ren Fail. 2020 Nov;42(1):107-112. doi: 10.1080/0886022X.2019.1710187.
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R.
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany.
Stachon P, Kaier K, Hehn P, Peikert A, Wolf D, Oettinger V, Staudacher D, Duerschmied D, Zirlik A, Zehender M, Bode C, von Zur Mühlen C.
Clin Res Cardiol. 2022 Jul;111(7):742-749. doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.
Coronary artery bypass grafting vs. drug-eluting stent implantation: the probabilities of reintervention, transition to severe care-need, nursing home, and death in patients with coronary artery disease within the first three years: evaluations based on health claims data in Germany.
Georges D, Kreft D, Doblhammer G.
J Thorac Dis. 2024 Aug 31;16(8):4863-4874. doi: 10.21037/jtd-24-251. Epub 2024 Aug 16.
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Suwannasom P, Tenekecioglu E, Yun SC, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
Coronary Artery Bypass at a Drug-Eluting Resorbable Magnesium Scaffold Site in a Porcine Model.
Cohen JE, Garcia-Garcia HM, Hellinga D, Kolodgie F, Virmani R, Finn A, Waksman R.
Cardiovasc Revasc Med. 2022 Sep;42:109-113. doi: 10.1016/j.carrev.2022.02.026. Epub 2022 Feb 28.
Coronary artery bypass grafting or percutaneous revascularization in acute myocardial infarction?
Perrier S, Kindo M, Gerelli S, Mazzucotelli JP.
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):1015-9. doi: 10.1093/icvts/ivt381. Epub 2013 Aug 20.
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease.
Chen X, Zhang X, Yan Y, Zhao X, Nie M, Feng T, Liang Z, Zhao Q.
J Interv Cardiol. 2020 Apr 20;2020:6736704. doi: 10.1155/2020/6736704. eCollection 2020.
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
Xu JJ, Gao Z, Zhang Y, Gao LJ, Chen J, Qiao SB, Gao RL, Yang YJ, Xu B, Yuan JQ.
Catheter Cardiovasc Interv. 2018 Feb 15;91(S1):566-572. doi: 10.1002/ccd.27500. Epub 2018 Jan 23.
A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.
Wang K, Wang L, Cong H, Zhang J, Hu Y, Zhang Y, Zhang R, Li W, Qi W.
ESC Heart Fail. 2022 Jun;9(3):1749-1755. doi: 10.1002/ehf2.13852. Epub 2022 Feb 22.
